Muscarinic receptors in the ocular surface

被引:8
作者
Enriquez-de-Salamanca, Amalia [1 ]
Calonge, Margarita [1 ]
机构
[1] Univ Valladolid, Fac Med, Ocular Surface Grp, IOBA,Inst Appl Ophthalmobiol, Valladolid 47005, Spain
关键词
conjunctiva; eye; muscarinic; neurogenic inflammation;
D O I
10.1097/01.all.0000244800.71851.0c
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review A wide distribution of the eye's muscarine receptor system has been found and several roles for the muscarinic system in the eye proposed, although functional consequences of muscarinic receptor activation are not always fully characterized. The present paper reviews current knowledge about the presence of muscarinic receptors in the ocular surface and the implication of the alterations on their expression and/or functioning in eye diseases. Recent findings Several authors have described alterations in muscarinic receptor subtype expression in the eye under pathological conditions. In conjunctiva of vernal keratoconjunctivitis patients, the expression of muscarinic receptor subtypes is altered in both the epithelium and stroma. Under proinflammatory conditions, M-muscarinic receptor expression is upregulated in conjunctival epithelial cells in vitro. M3-muscarinic receptor altered distribution has been found in the lacrimal gland NOD mice. Summary The cholinergic muscarinic system plays diverse roles. Alterations in the expression and/or functioning of muscarinic receptors may be implicated in the etiopathogenesis of some ocular diseases. Their pharmacological regulation may therefore have therapeutic value. Knowledge of the specific receptor subtypes expressed in each tissue may help to avoid some undesired secondary side effects in some cases when muscarinic agonists or antagonists are used.
引用
收藏
页码:379 / 382
页数:4
相关论文
共 33 条
  • [1] Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome
    Aragona, P
    Di Pietro, R
    Spinella, R
    Mobrici, M
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (02) : 166 - 170
  • [2] Bacman S, 1998, INVEST OPHTH VIS SCI, V39, P151
  • [3] THE MOLECULAR-BASIS OF MUSCARINIC RECEPTOR DIVERSITY
    BONNER, TI
    [J]. TRENDS IN NEUROSCIENCES, 1989, 12 (04) : 148 - 151
  • [4] Budd DC, 1999, MOL PHARMACOL, V56, P813
  • [5] Cha SH, 2006, J RHEUMATOL, V33, P296
  • [6] Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development
    da Costa, SR
    Wu, KJ
    Veigh, MM
    Pidgeon, M
    Ding, CQ
    Schechter, JE
    Hamm-Alvarez, SF
    [J]. EXPERIMENTAL EYE RESEARCH, 2006, 82 (01) : 33 - 45
  • [7] Regulation of mucin and fluid secretion by conjunctival epithelial cells
    Dartt, DA
    [J]. PROGRESS IN RETINAL AND EYE RESEARCH, 2002, 21 (06) : 555 - 576
  • [8] Vasoactive intestinal peptide-stimulated glycoconjugate secretion from conjunctival goblet cells
    Dartt, DA
    Kessler, TL
    Chung, EH
    Zieske, JD
    [J]. EXPERIMENTAL EYE RESEARCH, 1996, 63 (01) : 27 - 33
  • [9] Dartt DA, 2002, ADV EXP MED BIOL, V506, P297
  • [10] Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium
    de Salamanca, AE
    Siemasko, KF
    Diebold, Y
    Calonge, M
    Gao, JP
    Juárez-Campo, M
    Stern, ME
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (02) : 504 - 513